The transient eosinophilia did not appear to predict worse clinical outcomes, but it reflects the complex immune modulation when IL-4/IL-13 is blocked, as the latter effect could potentially cause eosinophils to temporarily redistribute from the tissues to blood (Castro et al., 2018a). This evidence concerns the gene IL13 and Increased total eosinophil count.